BRPI0818477A2 - Dc-sign, icam-3 e lsectin porcinos e usos dos mesmos - Google Patents

Dc-sign, icam-3 e lsectin porcinos e usos dos mesmos

Info

Publication number
BRPI0818477A2
BRPI0818477A2 BRPI0818477A BRPI0818477A2 BR PI0818477 A2 BRPI0818477 A2 BR PI0818477A2 BR PI0818477 A BRPI0818477 A BR PI0818477A BR PI0818477 A2 BRPI0818477 A2 BR PI0818477A2
Authority
BR
Brazil
Prior art keywords
lsectin
icam
pigs
sign
lsectin pigs
Prior art date
Application number
Other languages
English (en)
Portuguese (pt)
Inventor
Yaowei Huang
Xiang-Jin Meng
Original Assignee
Virginia Tech Intell Prop
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virginia Tech Intell Prop filed Critical Virginia Tech Intell Prop
Publication of BRPI0818477A2 publication Critical patent/BRPI0818477A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
BRPI0818477 2007-10-29 2008-10-29 Dc-sign, icam-3 e lsectin porcinos e usos dos mesmos BRPI0818477A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80007P 2007-10-29 2007-10-29
PCT/US2008/012251 WO2009058285A2 (en) 2007-10-29 2008-10-29 PORCINE DC-SIGN, ICAM-3 AND LSECtin AND USES THEREOF

Publications (1)

Publication Number Publication Date
BRPI0818477A2 true BRPI0818477A2 (pt) 2015-04-14

Family

ID=40591693

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0818477 BRPI0818477A2 (pt) 2007-10-29 2008-10-29 Dc-sign, icam-3 e lsectin porcinos e usos dos mesmos

Country Status (14)

Country Link
US (1) US8415118B2 (https=)
EP (2) EP2662384A1 (https=)
JP (1) JP2011501958A (https=)
KR (1) KR20100087344A (https=)
CN (1) CN102066415A (https=)
AU (1) AU2008319384A1 (https=)
BR (1) BRPI0818477A2 (https=)
CA (1) CA2704207A1 (https=)
CO (1) CO6270367A2 (https=)
MX (1) MX2010004548A (https=)
NZ (1) NZ584893A (https=)
RU (1) RU2010121862A (https=)
WO (1) WO2009058285A2 (https=)
ZA (1) ZA201002773B (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102947341B (zh) 2010-01-19 2018-07-06 哈佛大学校长及研究员协会 用于病原体检测和治疗的工程化调理素
WO2013012924A2 (en) 2011-07-18 2013-01-24 President And Fellows Of Harvard College Engineered microbe-targeting molecules and uses thereof
WO2013090806A2 (en) 2011-12-15 2013-06-20 Washington University Porcine knob xenotype chimeric adenoviral vector for dendritic cell infection
CN104284984B (zh) 2012-02-29 2017-10-13 哈佛大学校长及研究员协会 抗生素药敏性的快速测试
JP6254146B2 (ja) 2012-03-27 2017-12-27 エヌジーエム バイオファーマシューティカルス，インコーポレーテッド 代謝障害を治療するための組成物および方法
EP2976642A4 (en) 2013-03-15 2016-09-21 Harvard College METHOD AND COMPOSITIONS FOR IMPROVING THE DETECTION AND / OR RECORDING OF A TARGET UNIT
WO2014190040A1 (en) 2013-05-21 2014-11-27 President And Fellows Of Harvard College Engineered heme-binding compositions and uses thereof
EP3083658B1 (en) 2013-12-18 2019-05-08 President and Fellows of Harvard College Crp capture/detection of gram positive bacteria
MX370115B (es) 2014-07-30 2019-12-02 Ngm Biopharmaceuticals Inc Dímeros que comprenden dos polipéptidos, útiles en el tratamiento de trastornos metabólicos.
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
PL3212226T3 (pl) 2014-10-31 2020-11-02 Ngm Biopharmaceuticals, Inc. Kompozycje i sposoby stosowania w leczeniu zaburzeń metabolicznych
CN104749361B (zh) * 2015-01-21 2017-04-19 中国农业科学院哈尔滨兽医研究所 猪圆环病毒2型抗原捕获elisa试剂盒
CN105445457B (zh) * 2015-03-24 2017-08-11 中国农业科学院哈尔滨兽医研究所 检测猪圆环病毒2型Cap蛋白的单克隆抗体及试剂盒
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US10435457B2 (en) 2015-08-06 2019-10-08 President And Fellows Of Harvard College Microbe-binding molecules and uses thereof
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
CN106957847A (zh) * 2017-05-16 2017-07-18 吉林大学 有效抑制仔猪流行性腹泻病毒的siRNA及用途
CN107488635A (zh) * 2017-09-22 2017-12-19 中国人民解放军第三军医大学第三附属医院 单克隆细胞及其制备方法和用途
CN108893474B (zh) * 2018-02-07 2021-11-16 电子科技大学 草鱼细胞间粘附分子基因的分离和鉴定
CN108977444A (zh) * 2018-06-28 2018-12-11 西南大学 沉默荣昌猪CD14表达的siRNA及筛选方法与应用
CN109679952B (zh) * 2018-12-24 2022-04-15 西北农林科技大学 一种抗PRRSV感染的猪源miR-c89及其应用
CN109652384B (zh) * 2019-02-21 2021-10-26 昆明理工大学 一种体外培养戊型肝炎病毒的方法
CN109836478B (zh) * 2019-03-19 2022-06-14 扬州大学 非洲猪瘟病毒p11.5蛋白特异性多克隆抗体的制备方法及应用
CN109943536B (zh) * 2019-03-26 2021-09-14 昆明理工大学 一种戊型肝炎病毒的培养方法及其灭活疫苗的制备方法
CN111575409B (zh) * 2020-05-23 2023-04-18 黑龙江八一农垦大学 基于整合素配体识别肽抑制猪流行性腹泻病毒感染的研究方法
WO2022050476A1 (ko) * 2020-09-04 2022-03-10 이형우 인간 면역결핍 바이러스 감염 또는 감염 질환의 치료용 조성물
CN115725656B (zh) * 2021-09-01 2026-01-16 联邦生物科技(珠海横琴)有限公司 一种以细胞质rna病毒为载体递送干扰rna的方法
CN121454060A (zh) * 2026-01-05 2026-02-03 江苏立维斯德生物技术有限公司 一种基于免疫荧光法检测轮状病毒的方法、试剂盒及其用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2137547A1 (en) * 1992-06-11 1993-12-23 Daniel Meruelo Chimeric receptor polypeptides, human h13 proteins and uses thereof
GB9409768D0 (en) 1994-05-16 1994-07-06 Medical Res Council Trimerising polypeptides
US6146873A (en) 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
US6280953B1 (en) 1998-01-30 2001-08-28 Evolutionary Genomics, L.L.C. Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
JP2002543762A (ja) * 1999-03-25 2002-12-24 ブリストル−マイヤーズ スクイブ カンパニー ヒトｃｌａｘタンパク質およびその可溶性融合タンパク質をコードするｄｎａ分子
US6365156B1 (en) 1999-04-16 2002-04-02 Osel, Inc. Method for improving the half-life of soluble viral-specific ligands on mucosal membranes
EP1046651A1 (en) 1999-04-19 2000-10-25 Koninklijke Universiteit Nijmegen Composition and method for modulating dendritic cell-T interaction
US6391567B1 (en) 2000-03-02 2002-05-21 New York University Identifying compounds inhibiting DC-sign facilitation of HIV into cells
GB0318247D0 (en) * 2003-08-05 2003-09-10 Royal Veterinary College Antigen delivery system
BRPI0508762A (pt) 2004-04-16 2007-08-14 Genentech Inc método de aumento do esgotamento de células b em mamìferos, método de aumento da eficácia do esgotamento de células b, método de tratamento de malignidade ou neoplasma de células b, método de alìvio de disfunção autoimunológica regulada por células b, método de esgotamento das células b e composição

Also Published As

Publication number Publication date
JP2011501958A (ja) 2011-01-20
WO2009058285A9 (en) 2009-07-09
NZ584893A (en) 2012-08-31
US8415118B2 (en) 2013-04-09
US20100317054A1 (en) 2010-12-16
KR20100087344A (ko) 2010-08-04
CO6270367A2 (es) 2011-04-20
ZA201002773B (en) 2011-10-26
EP2207798A2 (en) 2010-07-21
WO2009058285A2 (en) 2009-05-07
CA2704207A1 (en) 2009-05-07
EP2662384A1 (en) 2013-11-13
WO2009058285A3 (en) 2009-12-10
RU2010121862A (ru) 2011-12-10
AU2008319384A1 (en) 2009-05-07
CN102066415A (zh) 2011-05-18
MX2010004548A (es) 2010-05-05

Similar Documents

Publication Publication Date Title
BRPI0818477A2 (pt) Dc-sign, icam-3 e lsectin porcinos e usos dos mesmos
BRPI1013943A2 (pt) Composto cetais e usos dos mesmos.
BRPI0920927A2 (pt) derivados de azaquinolinona e usos dos mesmos
BRPI0912198A2 (pt) anticorpos anti-fn14 e usos dos mesmos
BR112013016179A2 (pt) inibidores seletivos da glicosidase e usos dos mesmos.
BRPI1009455A2 (pt) anticorpos anti-c40 e usos dos mesmos
BRPI0822337A2 (pt) Folatos, composições e usos dos mesmos
BRPI0910503A2 (pt) compostos, composições farmacêuticas e respectivos usos.
BRPI0914682A2 (pt) compostos de heteroarila e usos dos mesmos
BRPI1009372A2 (pt) compostos, composição farmacêutica e respectivos usos
BRPI0819909A2 (pt) anticorpos antimesotelina e usos dos mesmos
HUE031343T2 (hu) Immunitásindukáló ágens
BRPI1014997A2 (pt) compostos heteroarila e usos dos mesmos
BRPI0921919A2 (pt) dispositivos médicos, aparelhos, sistemas e métodos
BRPI0908906A2 (pt) compostos heterocíclicos e usos dos mesmos
BRPI1016117A8 (pt) derivados de isoxazol-isoxazol e isoxazol-isotiazol.
IT1391276B1 (it) Casco perfezionato
BR112012000831A2 (pt) compostos, composições farmacêuticas e métodos relacionados
FI20096339L (fi) Liima-aine, menetelmä sen valmistamiseksi sekä sen käyttö
BR112012000379A2 (pt) composições de matriz carreadora, métodos e usos
IT1397694B1 (it) Puntale per attacchi da sci-alpinismo.
BRPI0915527A2 (pt) pepitídeos, composição farmacêutica e exossomos compreendendo os mesmos, métodos e usos
BRPI1014904A2 (pt) derivados de quinazolinadiona, preparação dos mesmos e vários usos terapêuticos dos mesmos.
HRP20160577T1 (hr) Liječenje osteoartritisa
BRPI0822143A2 (pt) derivados de dicicloaza-alcano, processos de preparação e usos médicos dos mesmos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.